Pre-Market Stock News (APR 3, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

(AAPL) Apple gets an inquiry from the EU over anti-trust issues into how its iTunes sells music online in coordination with major music companies.
(AIZ) Assurant will replace Realogy (H) in S&P 500 Index after close on Monday April 9.
(BG) Bunge actually lowered earnings guidance to $4.56 to $4.71 (after $0.23 Gain) versus $4.46 estimate for 2007 because of unrealized mark-to-market losses.
(CEGE) Cell Genesys said it showed longer survival time in prostate cancer studies from Phase II.
(CMGI) CMGI buys the other 60% of its joint venture in Japan in ModusLink unit.

(EAG) Eagle Broadband signed $6.4 million in deliveries of its advance IP video set-top boxes.
(EPX) Epix Pharma said it expects to receive non-compliance notice from NASDAQ.
(FMT) Freemont General said its auditor Grant Thornton has resigned.
(FTBK)Frontier Financial will replace Altiris (ATRS) in S&P Small Cap 600Index after ATRS is acquired by Symantec on a date TBA.
(IRBT) iRobot secured a $14M Navy order.
(ISCA) Int’l Speedway $0.70 EPS vs $0.75e.
(LBTYA) Liberty Global increased tender prices slightly.
(LEND) Accredited Home Lenders auditor Grant Thornton resigned.
(LWSN) Lawson delays earnings results, but said expectations
(MI) Marshall & Isley will spin-off its payment processing unit.
(NAPS) Napster raised guidance and said it ended with more than 830,000 subscribers.
(OPXA) Opexa Therapeutics showed positive Phase I/II dose escalation studies for MS.
(PEP) Pepsi will double workforce in China.
(QCOM) Qualcomm filed additional GSM patent infringement cases against Nokia.
(RPRX)Repros’ Proellex shows statistically significant improvements inprimary endpoint in its Phase II trials in treatment of uterinefibroids.
(TASR) Taser trading down almost 5% after lowering guidance because of order delays.
(THRX) Theravance rose 13% after positive Phase IIb studies in bronchodilators.

Jon C. Ogg
April 3, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618